6550--Notice of Intent to Sole-Source T-SPOT.TB® Reagents and Kits

Description: The Department of Veterans Affairs’ Network Contracting Office 2 intends to award a sole-source, firm-fixed-price contract to Euroimmun US Incorporated for T-SPOT.TB® reagents and kits used for tuberculosis testing at the VA Western New York Healthcare System’s Buffalo VA Medical Center. The notice states that the reagents are proprietary and FDA-cleared for use with the OEM platform, and that no other vendor can meet the stated FDA, CLIA, CAP, and Joint Commission requirements. This is not a request for competitive quotes, but interested parties may submit a one-page capability statement and proof of authorization by October 16, 2026, at 4:00 PM EDT.